Keyphrases
Kidney
100%
Transplantation
66%
Simultaneous Pancreas-kidney Transplantation
59%
Resection
57%
Tacrolimus
50%
Colorectal Liver Metastases
50%
Israel
49%
Liver
48%
Kidney Transplant Recipients
47%
Cyclosporine
41%
Kidney Transplantation
39%
Liver Transplantation
33%
Living Donor
31%
Pancreas
29%
Pancreaticoduodenectomy
29%
Quality of Life
27%
Cadaveric
25%
Liver Resection
24%
Pretransplant
23%
Neoadjuvant Chemotherapy
23%
Microemulsion
22%
Mycophenolate Mofetil
21%
Hypoperfusion
21%
Kidney Transplant
21%
Hepatic Colorectal Metastases
21%
Risk Factors
21%
Long-term Survival
20%
Rat Model
20%
Transplant Patients
20%
Postoperative Complications
20%
Clinical Presentation
19%
Corticosteroid Withdrawal
18%
Pancreatic Ductal Adenocarcinoma
18%
Hilar Cholangiocarcinoma
18%
Adult Liver Transplantation
18%
Laparoscopic Partial Nephrectomy
18%
Elderly Patients
18%
Neoadjuvant
18%
Donor Kidney
18%
Intention-to-treat Analysis
18%
MELD Score
18%
Transjugular Intrahepatic Portosystemic Shunt
18%
Nephrectomy
17%
Operative
17%
Chemotherapy
16%
Hepatic Resection
16%
Patient Selection
16%
Postoperative Mortality
16%
Dialysis
16%
Acute Portal Vein Thrombosis
16%
Medicine and Dentistry
Surgery
97%
Kidney Graft
67%
Kidney Pancreas Transplantation
58%
Transplantation
57%
Kidney Transplantation
56%
Hepatectomy
53%
Colorectal Liver Metastasis
48%
Metastatic Carcinoma
41%
Liver Transplantation
41%
Neoplasm
40%
Pancreaticoduodenectomy
29%
Disease
28%
Creatinine
28%
Nephrectomy
26%
Neoadjuvant Chemotherapy
25%
Graft Failure
25%
Mycophenolic Acid
25%
Pancreas Cancer
23%
Cyclosporine
23%
Survival Rate
23%
End Stage Liver Disease
21%
Organ Transplantation
21%
Postoperative Complication
20%
Quality of Life
20%
Cholangiocarcinoma
19%
Tacrolimus
18%
Transjugular Intrahepatic Portosystemic Shunt
18%
Low Drug Dose
18%
Elderly Patient
18%
Kidney Allograft
18%
Intention-to-Treat Analysis
18%
Malignant Neoplasm
18%
Allograft
17%
Recurrent Disease
16%
Portal Vein Thrombosis
16%
Long Term Survival
15%
Kidney Function
14%
Surgeon
14%
Overall Survival
14%
Diabetes Mellitus
13%
Computer Assisted Tomography
13%
Hepatic Portal Vein
13%
Soft Tissue Sarcoma
13%
Disease Course
12%
Peroperative Complication
12%
Intraductal Papillary Mucinous Tumor
12%
Neoadjuvant Therapy
12%
Fulminant Hepatic Failure
12%
Hepatocellular Carcinoma
12%
Donor Selection
11%